Clinical trial
BCG Vaccine to Reduce Unplanned Absenteeism Due to Illness of Health Care Workers During the COVID-19 Pandemic. A Multi-center Randomised Controlled Trial (BCG-COVID-RCT)
NCT04641858 is registered in ClinicalTrials.gov with University of Southern Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BCG Vaccine to Reduce Unplanned Absenteeism Due to Illness of Health Care Workers During the COVID-19 Pandemic. A Multi-center Randomised Controlled Trial (BCG-COVID-RCT)
- Lead sponsor
- University of Southern Denmark
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 3, 2020
- Completion date
- July 13, 2022
- Enrollment
- 668 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
absenteeism, covid19, morbidity